Abstract
Primary neuroendocrine carcinomas of the breast are extremely rare. Tumours can only be considered small cell neuroendocrine tumour of the breast if nonmammary sites are excluded. These tumours form a diagnostic and therapeutic challenge. We present our experience of small cell neuroendocrine tumour of the breast and discuss a review of the relevant literature.
MeSH terms
-
Aged
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Biopsy / methods
-
Breast / pathology*
-
Breast Neoplasms / diagnosis*
-
Breast Neoplasms / therapy
-
Carcinoma, Small Cell / diagnosis*
-
Carcinoma, Small Cell / therapy
-
Combined Modality Therapy
-
Female
-
Humans
-
Magnetic Resonance Imaging
-
Mastectomy, Modified Radical / methods
-
Tamoxifen / therapeutic use
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Hormonal
-
Tamoxifen